Sign in

CIK 0001832038

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Invivyd, Inc.

Sign in to watch
Ticker
IVVD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851403134
Phone
+1 781-819-0080
Business address
205 CHURCH STREET, NEW HAVEN, CT
Former names
Adagio Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-12-18 Hering David Chief Executive Officer Grant or award · Stock Option (Right to Buy) +950,000 950,000
2022-12-14 Hering David Chief Executive Officer Grant or award · Stock Option (Right to Buy) +700,000 700,000
2022-12-14 Hering David Chief Executive Officer Grant or award · Stock Option (Right to Buy) +900,000 900,000
2022-09-01 Hering David Chief Executive Officer Purchase +8,000 $4.52 $36K 8,000
2022-07-05 Hering David Chief Executive Officer Grant or award · Stock Option (Right to Buy) +2,000,000 2,000,000
2022-01-30 Hering David Chief Operating Officer Grant or award · Stock Option (Right to Buy) +475,000 475,000

Page 1 of 1 · 6 trades